J Physiol Wellcome Trust-funded researchers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 523, Number 3, 561-574, March 15, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kockskämper, J.
Right arrow Articles by Glitsch, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kockskämper, J.
Right arrow Articles by Glitsch, H. G.
The Journal of Physiology (2000), 523.3, pp. 561-574
© Copyright 2000 The Physiological Society

Activation of the cAMP-protein kinase A pathway facilitates Na+ translocation by the Na+-K+ pump in guinea-pig ventricular myocytes

Jens Kockskämper, Simone Erlenkamp and Helfried G. Glitsch

Arbeitsgruppe Muskelphysiologie, Fakultät für Biologie, Ruhr-Universität, D-44780 Bochum, Germany

  1. The effects of the adenylyl cyclase activator forskolin on steady-state and transient currents generated by the Na+-K+ pump were studied in guinea-pig ventricular myocytes by means of whole-cell voltage clamp at 30 °C.

  2. In external solution containing 144 mM Na+ (Na+o) and 10 mM K+ (K+o), steady-state Na+-K+ pump current (Ip) activated by 5 mM pipette Na+ (Na+pip) at -20 mV was reversibly augmented by forskolin (4 µM) to 133 ± 4 % of the control current (n = 15). The forskolin analogue 1,9-dideoxyforskolin (10 µM), which does not activate adenylyl cyclases, did not increase Ip (n = 2). Application of the protein kinase A (PKA) inhibitor H-89 (10 µM) in the continued presence of forskolin reversed the forskolin-induced elevation of Ip (n = 3).

  3. The forskolin effect on Ip persisted in the presence of 50 mM Na+pip which ensured that the internal Na+-binding sites of the Na+-K+ pump were nearly saturated. Under these conditions, the drug increased Ip to 142 ± 3 % of the control Ip when the pipette free Ca2+ concentration ([Ca2+]pip) was 0·013 nM (n = 5) and to 138 ± 4 % of the control Ip when free [Ca2+]pip was 15 nM (n = 9).

  4. In Na+-free external solution, Ip activated by 50 mM Na+pip and 1·5 mM K+o was likewise increased by forskolin but to a lesser extent than in Na+-containing medium (116 ± 3 % of control, n = 10).

  5. In order to investigate exclusively partial reactions in the Na+ limb of the pump cycle, transient pump currents under conditions of electroneutral Na+-Na+ exchange were studied. Transient pump currents elicited by voltage jumps displayed an initial peak and then decayed monoexponentially. Moved charge (Q) and the rate constant of current decay varied with membrane potential (V). The Q-V relationship followed a Boltzmann distribution characterized by the midpoint voltage (V0·5) and the maximum amount of movable charge (DeltaQmax). Forskolin (2-10 µM) shifted V0·5 to more negative values while DeltaQmax was not affected (n = 11). The effects of forskolin on transient pump currents were mimicked by 8-bromo-cAMP (500 µM; n = 2) and abolished by a peptide inhibitor of PKA (PKI, 10 µM; n = 5).

  6. We conclude that activation of the cAMP-PKA pathway in guinea-pig ventricular myocytes increases Na+-K+ pump current at least in part by modulating partial reactions in the Na+ limb of the pump cycle. Under physiological conditions, the observed stimulation of the cardiac Na+-K+ pump may serve to shorten the action potential duration and to counteract the increased passive sarcolemmal Na+ and K+ fluxes during sympathetic stimulation of the heart.



This article has been cited by other articles:


Home page
Circ. Res.Home page
S. Despa, J. Bossuyt, F. Han, K. S. Ginsburg, L.-G. Jia, H. Kutchai, A. L. Tucker, and D. M. Bers
Phospholemman-Phosphorylation Mediates the {beta}-Adrenergic Effects on Na/K Pump Function in Cardiac Myocytes
Circ. Res., August 5, 2005; 97(3): 252 - 259.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. d.Z. Silverman, W. Fuller, P. Eaton, J. Deng, J. R. Moorman, J. Y. Cheung, A. F. James, and M. J. Shattock
Serine 68 phosphorylation of phospholemman: acute isoform-specific activation of cardiac Na/K ATPase
Cardiovasc Res, January 1, 2005; 65(1): 93 - 103.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
H. G. Glitsch
Electrophysiology of the Sodium-Potassium-ATPase in Cardiac Cells
Physiol Rev, October 1, 2001; 81(4): 1791 - 1826.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
O. M. Sejersted and G. Sjogaard
Dynamics and Consequences of Potassium Shifts in Skeletal Muscle and Heart During Exercise
Physiol Rev, October 1, 2000; 80(4): 1411 - 1481.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 The Physiological Society.